BioBen joined Archer Capital in 2004 during the investment period of Archer Capital Fund 2. He has been responsible for Archer’s investments in Allity, Healthe Care, iNova Pharmaceuticals, LCR Group and SULO and was involved in the original platform investments leading to the formation of Rebel Group. Ben is currently chairman of Allity and LCR Group and is a member of the Archer Capital Investment Committee.
Education